Stay updated with breaking news from Pharma Corp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled...
CTI BioPharma Corp. (NASDAQ:CTIC – Get Rating) has earned an average rating of “Buy” from the nine research firms that are currently covering the firm, Marketbeat reports. One research analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation and seven have given a buy recommendation to the company. The […]
CTI BioPharma Corp. (NASDAQ:CTIC – Get Rating) has been assigned a consensus rating of “Buy” from the nine research firms that are presently covering the company, Marketbeat.com reports. One analyst has rated the stock with a sell rating, one has assigned a hold rating and seven have assigned a buy rating to the company. The […]
Wall Street analysts predict that CTI BioPharma Corp. (NASDAQ:CTIC – Get Rating) will post earnings of $0.18 per share for the current fiscal quarter, Zacks reports. Two analysts have provided estimates for CTI BioPharma’s earnings. The highest EPS estimate is $0.38 and the lowest is ($0.02). CTI BioPharma reported earnings of ($0.23) per share in […]
Brokerages expect that CTI BioPharma Corp. (NASDAQ:CTIC – Get Rating) will announce sales of $61.40 million for the current fiscal quarter, Zacks Investment Research reports. Two analysts have provided estimates for CTI BioPharma’s earnings. The lowest sales estimate is $60.20 million and the highest is $62.60 million. The business is scheduled to report its next […]